ARISING HEALTHALIVE. AWAKE. AWARE.Read the magazines →

← All editions

THE ARISING · EDITED READER EDITION

The Arising · November 14 Edited Reader Edition

This edited reader edition includes 3 reviewed articles from November 14, 2026. It is not the complete original issue. It includes 3 of the original 41 stories; 38 are not included here.

Longevity & Healthspan

Some epigenetic clocks responded to interventions. That is not proof of slower aging.

November 14, 2026 · Longevity & Healthspan

An epigenetic clock turns a pattern of chemical marks on DNA into a score. If that score changes after a treatment, does it mean the treatment will help people stay healthy longer? A Nature Medicine analysis tackles the first part of the question: how often and how consistently the scores respond.

The authors assembled data from 51 human intervention studies and applied 16 established epigenetic clocks. In the compiled data, drug and lifestyle interventions lowered estimated epigenetic age when analyzed as categories. Supplements did not show a clear reduction as a group. That does not rule out effects from any individual supplement, or establish that a particular drug slows aging.

The clocks themselves responded differently. Those designed to estimate mortality risk or the pace of aging tended to respond more strongly, while the study population and length of follow-up also mattered. The team compared categories drawn from different studies, not treatments assigned head to head in a single large trial.

The practical question for researchers is whether a responsive score can reliably predict what happens to people after treatment. This study did not establish that clock changes translate into longer life, less disease, or better function. A test can register a change without establishing that the change improves health.

The paper was published online August 21, 2026, and is revisited in this November issue.

Primary source: Sehgal and colleagues, *Nature Medicine*

Open this article on its own →

Longevity & Healthspan

Fluid waves during sleep were smaller in older adults

November 14, 2026 · Longevity & Healthspan

The sleeping brain is not still. A study in Nature Aging tracked electrical rhythms, changes in blood dynamics and waves of cerebrospinal fluid during nighttime sleep. The fluid waves were smaller in the older adults the researchers studied.

The scientists compared adults aged 18 to 39 with adults aged 60 to 84. The smaller waves in older participants went along with weaker slow electrical rhythms during sleep and smaller rhythmic changes in blood dynamics. They also tracked with differences in gray matter.

In separate experiments during wakefulness, the researchers probed whether changing neural activity or blood-vessel responses could affect fluid movement. The findings support a role for both. That matters because losing a rhythm that helps drive the flow and changing how vessels respond are not necessarily the same problem.

The sleep comparison was a snapshot of two age groups, not a decades-long record of the same people. The researchers measured fluid movement, not how much waste any participant's brain removed. Nor did the work show that changing these waves would prevent cognitive decline or dementia. A familiar metaphor about the brain being “washed clean” during sleep should not be mistaken for what this study measured.

Repeating these measurements over time could help researchers learn whether changes in flow track with later changes in memory or thinking. For now, the result shows a difference in sleep physiology worth investigating, not a new health test or treatment.

Primary source: Bailes and colleagues, *Nature Aging*, November 13, 2026

Open this article on its own →

Longevity & Healthspan

A research smartwatch flagged possible high blood pressure, not a diagnosis

November 14, 2026 · Longevity & Healthspan

A study in Nature tested whether a consumer smartwatch could flag signs of high blood pressure from pulse and motion signals. The system did not give a blood pressure reading. It was designed to identify people who might benefit from a proper blood pressure check.

The researchers tested the system in 196 adults who had no known cardiovascular disease and were not taking blood pressure medicine. Participants wore the watch for seven days. The researchers compared its flags and initial office screening with results from a 24-hour ambulatory cuff monitor.

The experimental watch system flagged about 66% of participants whom the ambulatory monitor identified as having high blood pressure. The initial office screen identified about 55%. Both correctly did not flag about 90% of participants who did not have it. Those estimates are uncertain; the study does not establish that the watch outperforms office screening or can replace it. The watch missed about one in three people with high blood pressure in this sample.

An alert could prompt someone to get checked. It is not a diagnosis, and no alert is not an all-clear. This was a test of one research system in one selected sample, not evidence that all watches on the market can do this. The study also did not test whether deploying the system in everyday practice improves health.

Primary source: Di Achille and colleagues, *Nature*, November 5, 2026

Open this article on its own →

THE ARISING NEWSLETTER

Science moves forward.
Come with it.

Research, clear explanations, and a little room for wonder.
Read and follow The Arising on Substack.

Find The Arising on Substack ↗